5_63277676249103782hebskebdjeejeje11.pptx

Ppt

1. Overweight and Obesity

2. Fat Mass Is an Endocrine Organ

3. Obesity Is a Chronic Disease

4. Obesity Is a Gateway Disease Related to More Than 200 Diseases

5. Energy and Appetite Regulation

6. Dysregulated Energy and Appetite Regulation in Obesity

7. Physiological Factors Affecting Weight Regain

8. Body Weight Setpoint

9. Underlying Causes of Obesity and Factors Potentially Contributing to Weight Gain or Impairing Weight Loss

10. Framework for Obesity Management

11. Is Substantial, Stable, Long-Term Weight Loss Possible?

12. Weight Regain After Stopping Pharmacotherapy

13. Emily Case History

14. Emily On Examination

15. Underlying Causes of Obesity and Factors Potentially Contributing to Weight Gain or Impairing Weight Loss

16. Emily Next Steps

17. Titrating Naltrexone-Bupropion

18. Adverse Effects and Contraindications Naltrexone-Bupropion

19. Follow-Up

20. Obesity Pharmacotherapy for Adults

21. Anti-Obesity Medications for Adults Impact on Obesity-Related Comorbidities

22. Incretin-Based Pharmacotherapy for Obesity in Adults Impact on Obesity-Related Comorbidities

23. Weight Loss in the STEP Trials

24. Long-Term Weight Reduction in STEP 5

25. Weight Regain in the STEP 1 Extension Trial

26. CVOTs of Anti-Obesity Medications

27. MACE in the SELECT Trial

28. GLP-1 RAs and Reduction in MACE

29. Other Health Effects of Semaglutide 2.4 mg

30. Weight Loss in the SURMOUNT Trials

31. Long-Term Weight Maintenance in SURMOUNT 4 Trial

32. Other Health Effects of Tirzepatide

33. Summary

34. Ameera Case Study

35. Ameera Weight Management Goals

36. Ameera Next Best Step

37. Titrating Semaglutide for Obesity Management

38. Adverse Effects to Anticipate

39. Contraindications With Novel Anti-Obesity Medications

40. Weight Bias and Stigma in Healthcare Interactions

41. Starting a Conversation About Obesity With Patients

42. Dos and Don’ts

43. Framework for Obesity Management

44. The 3 Pillars of Obesity Management

45. Ask About Appetite

46. Incretin-Based Anti-Obesity Medications

47. Titrating Liraglutide for Obesity Management

48. Titrating Semaglutide for Obesity Management

49. Titrating Tirzepatide for Obesity Management

50. Slow Escalation to the Appropriate Dose

51. Summary

52. Sarah Case History

53. Ask About Appetite

54. Sarah Next Best Step

55. Titrating Tirzepatide for Obesity Management

56. Counsel Patients on Need for Long-Term Therapy

57. Adverse Events, Contraindications, Interactions

58. Sarah Progress